Dermapharm Holding SE (DMPHF)
59.00
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Dermapharm Market Cap : 3.177B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 568.50B |
| ANI Pharmaceuticals, Inc. | 1.858B |
| Corcept Therapeutics, Inc. | 8.314B |
| Assertio Holdings, Inc. | 151.24M |
| Veru, Inc. | 50.56M |
Market Cap Related Metrics
| PE Ratio | 18.94 |
| PS Ratio | 2.345 |
| PEG Ratio | 0.3731 |
| Price to Book Value | 3.731 |
| Price to Free Cash Flow | 14.28 |
| Price | 59.00 |
| Earnings Yield | 5.28% |
| PEGY Ratio | 0.3604 |
| Operating PE Ratio | 11.54 |
| Normalized PE Ratio | 18.45 |